---
layout: default
title: Papers
parent: Assets
---

# Academic Papers
{: .no_toc }

## Table of contents
{: .no_toc .text-delta }

1. TOC
{:toc}

---

## Spacing

Abrams P, et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. 2002; 21:167-78. doi: [10.1002/nau.10052](https://doi.org/10.1002/nau.10052)


Bump RC, et al.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. 1996; 175:10-7. doi: [10.1016/s0002-9378(96)70243-0](https://doi.org/10.1016/s0002-9378(96)70243-0)


Irwin DE, et al.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. 2006; 50:1306-14; discussion 1314-5. doi: [10.1016/j.eururo.2006.09.019](https://doi.org/10.1016/j.eururo.2006.09.019)


Haylen BT, et al.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. 2010; 21:5-26. doi: [10.1007/s00192-009-0976-9](https://doi.org/10.1007/s00192-009-0976-9)


Olsen AL, et al.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. 1997; 89:501-6. doi: [10.1016/S0029-7844(97)00058-6](https://doi.org/10.1016/S0029-7844(97)00058-6)


Nygaard I, et al.  Prevalence of symptomatic pelvic floor disorders in US women. 2008; 300:1311-6. doi: [10.1001/jama.300.11.1311](https://doi.org/10.1001/jama.300.11.1311)


Schäfer W, et al.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. 2002; 21:261-74. doi: [10.1002/nau.10066](https://doi.org/10.1002/nau.10066)


Wu JM, et al.  Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. 2014; 123:1201-1206. doi: [10.1097/AOG.0000000000000286](https://doi.org/10.1097/AOG.0000000000000286)


Milsom I, et al.  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. 2001; 87:760-6. doi: [10.1046/j.1464-410x.2001.02228.x](https://doi.org/10.1046/j.1464-410x.2001.02228.x)


Gormley EA, et al.  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. 2015; 193:1572-80. doi: [10.1016/j.juro.2015.01.087](https://doi.org/10.1016/j.juro.2015.01.087)


Irwin DE, et al.  Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. 2011; 108:1132-8. doi: [10.1111/j.1464-410X.2010.09993.x](https://doi.org/10.1111/j.1464-410X.2010.09993.x)


Gormley EA, et al.  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. 2012; 188:2455-63. doi: [10.1016/j.juro.2012.09.079](https://doi.org/10.1016/j.juro.2012.09.079)


Avery K, et al.  ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. 2004; 23:322-30. doi: [10.1002/nau.20041](https://doi.org/10.1002/nau.20041)


Khullar V, et al.  Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. 2013; 63:283-95. doi: [10.1016/j.eururo.2012.10.016](https://doi.org/10.1016/j.eururo.2012.10.016)


Altman D, et al.  Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. 2011; 364:1826-36. doi: [10.1056/NEJMoa1009521](https://doi.org/10.1056/NEJMoa1009521)


Richter HE, et al.  Retropubic versus transobturator midurethral slings for stress incontinence. 2010; 362:2066-76. doi: [10.1056/NEJMoa0912658](https://doi.org/10.1056/NEJMoa0912658)


Hanno PM, et al.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. 2011; 185:2162-70. doi: [10.1016/j.juro.2011.03.064](https://doi.org/10.1016/j.juro.2011.03.064)


Coyne KS, et al.  The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. 2008; 101:1388-95. doi: [10.1111/j.1464-410X.2008.07601.x](https://doi.org/10.1111/j.1464-410X.2008.07601.x)


Nitti VW, et al.  Results of a randomized phase III trial of mirabegron in patients with overactive bladder. 2013; 189:1388-95. doi: [10.1016/j.juro.2012.10.017](https://doi.org/10.1016/j.juro.2012.10.017)


Rockwood TH, et al.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. 2000; 43:9-16; discussion 16-7. doi: [10.1007/BF02237236](https://doi.org/10.1007/BF02237236)


Chapple C, et al.  OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. 2013; 64:249-56. doi: [10.1016/j.eururo.2013.04.001](https://doi.org/10.1016/j.eururo.2013.04.001)


Wagg A, et al.  Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. 2012; 110:1767-74. doi: [10.1111/j.1464-410X.2012.11023.x](https://doi.org/10.1111/j.1464-410X.2012.11023.x)


Hendrix SL, et al.  Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. 2002; 186:1160-6. doi: [10.1067/mob.2002.123819](https://doi.org/10.1067/mob.2002.123819)


Barber MD, et al.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). 2005; 193:103-13. doi: [10.1016/j.ajog.2004.12.025](https://doi.org/10.1016/j.ajog.2004.12.025)


Cruz F, et al.  Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. 2011; 60:742-50. doi: [10.1016/j.eururo.2011.07.002](https://doi.org/10.1016/j.eururo.2011.07.002)


Abrams P, et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. 2002; 187:116-26. doi: [10.1067/mob.2002.125704](https://doi.org/10.1067/mob.2002.125704)


Smith FJ, et al.  Lifetime risk of undergoing surgery for pelvic organ prolapse. 2010; 116:1096-100. doi: [10.1097/AOG.0b013e3181f73729](https://doi.org/10.1097/AOG.0b013e3181f73729)


Nager CW, et al.  A randomized trial of urodynamic testing before stress-incontinence surgery. 2012; 366:1987-97. doi: [10.1056/NEJMoa1113595](https://doi.org/10.1056/NEJMoa1113595)


Novara G, et al.  Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. 2010; 58:218-38. doi: [10.1016/j.eururo.2010.04.022](https://doi.org/10.1016/j.eururo.2010.04.022)


Uebersax JS, et al.  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. 1995; 14:131-9. doi: [10.1002/nau.1930140206](https://doi.org/10.1002/nau.1930140206)


Chapple CR, et al.  Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder. 2013; 63:296-305. doi: [10.1016/j.eururo.2012.10.048](https://doi.org/10.1016/j.eururo.2012.10.048)


Nitti VW, et al.  OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. 2013; 189:2186-93. doi: [10.1016/j.juro.2012.12.022](https://doi.org/10.1016/j.juro.2012.12.022)


de Leval J.  Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. 2003; 44:724-30. doi: [10.1016/j.eururo.2003.09.003](https://doi.org/10.1016/j.eururo.2003.09.003)


Ginsberg D, et al.  Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. 2012; 187:2131-9. doi: [10.1016/j.juro.2012.01.125](https://doi.org/10.1016/j.juro.2012.01.125)


Paraiso MFR, et al.  Laparoscopic compared with robotic sacrocolpopexy for vaginal prolapse: a randomized controlled trial. 2011; 118:1005-1013. doi: [10.1097/AOG.0b013e318231537c](https://doi.org/10.1097/AOG.0b013e318231537c)


Wu JM, et al.  Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. 2009; 114:1278-1283. doi: [10.1097/AOG.0b013e3181c2ce96](https://doi.org/10.1097/AOG.0b013e3181c2ce96)


DeLancey JO, et al.  Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapse. 2007; 109:295-302. doi: [10.1097/01.AOG.0000250901.57095.ba](https://doi.org/10.1097/01.AOG.0000250901.57095.ba)


Wu JM, et al.  Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. 2014; 123:141-148. doi: [10.1097/AOG.0000000000000057](https://doi.org/10.1097/AOG.0000000000000057)


Nilsson CG, et al.  Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. 2008; 19:1043-7. doi: [10.1007/s00192-008-0666-z](https://doi.org/10.1007/s00192-008-0666-z)


Subak LL, et al.  Weight loss to treat urinary incontinence in overweight and obese women. 2009; 360:481-90. doi: [10.1056/NEJMoa0806375](https://doi.org/10.1056/NEJMoa0806375)


Stöhrer M, et al.  EAU guidelines on neurogenic lower urinary tract dysfunction. 2009; 56:81-8. doi: [10.1016/j.eururo.2009.04.028](https://doi.org/10.1016/j.eururo.2009.04.028)


Stewart WF, et al.  Prevalence and burden of overactive bladder in the United States. 2003; 20:327-36. doi: [10.1007/s00345-002-0301-4](https://doi.org/10.1007/s00345-002-0301-4)


Schurch B, et al.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. 2000; 164:692-7. doi: [10.1097/00005392-200009010-00018](https://doi.org/10.1097/00005392-200009010-00018)


Nguyen JN and Burchette RJ.  Outcome after anterior vaginal prolapse repair: a randomized controlled trial. 2008; 111:891-8. doi: [10.1097/AOG.0b013e31816a2489](https://doi.org/10.1097/AOG.0b013e31816a2489)


van Kerrebroeck PE, et al.  Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. 2007; 178:2029-34. doi: [10.1016/j.juro.2007.07.032](https://doi.org/10.1016/j.juro.2007.07.032)


Schurch B, et al.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. 2005; 174:196-200. doi: [10.1097/01.ju.0000162035.73977.1c](https://doi.org/10.1097/01.ju.0000162035.73977.1c)


Dmochowski R, et al.  Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. 2010; 184:2416-22. doi: [10.1016/j.juro.2010.08.021](https://doi.org/10.1016/j.juro.2010.08.021)


Nilsson CG, et al.  Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. 2013; 24:1265-9. doi: [10.1007/s00192-013-2090-2](https://doi.org/10.1007/s00192-013-2090-2)


Rogers RG, et al.  A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). 2003; 14:164-8; discussion 168. doi: [10.1007/s00192-003-1063-2](https://doi.org/10.1007/s00192-003-1063-2)


Barber MD, et al.  Defining success after surgery for pelvic organ prolapse. 2009; 114:600-609. doi: [10.1097/AOG.0b013e3181b2b1ae](https://doi.org/10.1097/AOG.0b013e3181b2b1ae)


Thüroff JW, et al.  EAU guidelines on urinary incontinence. 2011; 59:387-400. doi: [10.1016/j.eururo.2010.11.021](https://doi.org/10.1016/j.eururo.2010.11.021)


Dietz HP and Simpson JM.  Levator trauma is associated with pelvic organ prolapse. 2008; 115:979-84. doi: [10.1111/j.1471-0528.2008.01751.x](https://doi.org/10.1111/j.1471-0528.2008.01751.x)


Herschorn S, et al.  A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder. 2013; 82:313-20. doi: [10.1016/j.urology.2013.02.077](https://doi.org/10.1016/j.urology.2013.02.077)


Berry SH, et al.  Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. 2011; 186:540-4. doi: [10.1016/j.juro.2011.03.132](https://doi.org/10.1016/j.juro.2011.03.132)


Swift S, et al.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. 2005; 192:795-806. doi: [10.1016/j.ajog.2004.10.602](https://doi.org/10.1016/j.ajog.2004.10.602)


Dietz HP and Lanzarone V.  Levator trauma after vaginal delivery. 2005; 106:707-12. doi: [10.1097/01.AOG.0000178779.62181.01](https://doi.org/10.1097/01.AOG.0000178779.62181.01)


Brubaker L, et al.  Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. 2006; 354:1557-66. doi: [10.1056/NEJMoa054208](https://doi.org/10.1056/NEJMoa054208)


Hunskaar S, et al.  The prevalence of urinary incontinence in women in four European countries. 2004; 93:324-30. doi: [10.1111/j.1464-410x.2003.04609.x](https://doi.org/10.1111/j.1464-410x.2003.04609.x)


Albo ME, et al.  Burch colposuspension versus fascial sling to reduce urinary stress incontinence. 2007; 356:2143-55. doi: [10.1056/NEJMoa070416](https://doi.org/10.1056/NEJMoa070416)


Yalcin I and Bump RC.  Validation of two global impression questionnaires for incontinence. 2003; 189:98-101. doi: [10.1067/mob.2003.379](https://doi.org/10.1067/mob.2003.379)


Fatton B, et al.  Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift technique)--a case series multicentric study. 2007; 18:743-52. doi: [10.1007/s00192-006-0234-3](https://doi.org/10.1007/s00192-006-0234-3)


Lucas MG, et al.  EAU guidelines on assessment and nonsurgical management of urinary incontinence. 2012; 62:1130-42. doi: [10.1016/j.eururo.2012.08.047](https://doi.org/10.1016/j.eururo.2012.08.047)


Apostolidis A, et al.  Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. 2005; 174:977-82; discussion 982-3. doi: [10.1097/01.ju.0000169481.42259.54](https://doi.org/10.1097/01.ju.0000169481.42259.54)


Ward KL, et al.  A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. 2004; 190:324-31. doi: [10.1016/j.ajog.2003.07.029](https://doi.org/10.1016/j.ajog.2003.07.029)


Homma Y, et al.  Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. 2006; 68:318-23. doi: [10.1016/j.urology.2006.02.042](https://doi.org/10.1016/j.urology.2006.02.042)


Benner JS, et al.  Patient-reported reasons for discontinuing overactive bladder medication. 2010; 105:1276-82. doi: [10.1111/j.1464-410X.2009.09036.x](https://doi.org/10.1111/j.1464-410X.2009.09036.x)


Kuuva N and Nilsson CG.  A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure. 2002; 81:72-7. doi: [10.1034/j.1600-0412.2002.810113.x](https://doi.org/10.1034/j.1600-0412.2002.810113.x)


Lucas MG, et al.  EAU guidelines on surgical treatment of urinary incontinence. 2012; 62:1118-29. doi: [10.1016/j.eururo.2012.09.023](https://doi.org/10.1016/j.eururo.2012.09.023)


DeLancey JO.  Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. 1994; 170:1713-20; discussion 1720-3. doi: [10.1016/s0002-9378(94)70346-9](https://doi.org/10.1016/s0002-9378(94)70346-9)


Freeman RM, et al.  A randomised controlled trial of abdominal versus laparoscopic sacrocolpopexy for the treatment of post-hysterectomy vaginal vault prolapse: LAS study. 2013; 24:377-84. doi: [10.1007/s00192-012-1885-x](https://doi.org/10.1007/s00192-012-1885-x)


Wei JT, et al.  A midurethral sling to reduce incontinence after vaginal prolapse repair. 2012; 366:2358-67. doi: [10.1056/NEJMoa1111967](https://doi.org/10.1056/NEJMoa1111967)


Peters KM, et al.  Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. 2010; 183:1438-43. doi: [10.1016/j.juro.2009.12.036](https://doi.org/10.1016/j.juro.2009.12.036)


Rockwood TH, et al.  Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. 1999; 42:1525-32. doi: [10.1007/BF02236199](https://doi.org/10.1007/BF02236199)


Maher CM, et al.  Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review. 2011; 22:1445-57. doi: [10.1007/s00192-011-1542-9](https://doi.org/10.1007/s00192-011-1542-9)


van Kerrebroeck P, et al.  The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. 2002; 21:179-83. doi: [10.1002/nau.10053](https://doi.org/10.1002/nau.10053)


DeLancey JO, et al.  The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery. 2003; 101:46-53. doi: [10.1016/s0029-7844(02)02465-1](https://doi.org/10.1016/s0029-7844(02)02465-1)


Dietz HP, et al.  Biometry of the pubovisceral muscle and levator hiatus by three-dimensional pelvic floor ultrasound. 2005; 25:580-5. doi: [10.1002/uog.1899](https://doi.org/10.1002/uog.1899)


Hendrix SL, et al.  Effects of estrogen with and without progestin on urinary incontinence. 2005; 293:935-48. doi: [10.1001/jama.293.8.935](https://doi.org/10.1001/jama.293.8.935)


Weber AM, et al.  Anterior colporrhaphy: a randomized trial of three surgical techniques. 2001; 185:1299-304; discussion 1304-6. doi: [10.1067/mob.2001.119081](https://doi.org/10.1067/mob.2001.119081)


Peters KM, et al.  Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. 2009; 182:1055-61. doi: [10.1016/j.juro.2009.05.045](https://doi.org/10.1016/j.juro.2009.05.045)


Hiltunen R, et al.  Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial. 2007; 110:455-62. doi: [10.1097/01.AOG.0000261899.87638.0a](https://doi.org/10.1097/01.AOG.0000261899.87638.0a)


Maher CF, et al.  Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study. 2004; 190:20-6. doi: [10.1016/j.ajog.2003.08.031](https://doi.org/10.1016/j.ajog.2003.08.031)


Ward KL, et al.  Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. 2008; 115:226-33. doi: [10.1111/j.1471-0528.2007.01548.x](https://doi.org/10.1111/j.1471-0528.2007.01548.x)


Leach GE, et al.  Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. 1997; 158:875-80. doi: [10.1097/00005392-199709000-00054](https://doi.org/10.1097/00005392-199709000-00054)


Tikkinen KA, et al.  Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. 2010; 57:488-96. doi: [10.1016/j.eururo.2009.03.080](https://doi.org/10.1016/j.eururo.2009.03.080)


Dietz HP, et al.  Minimal criteria for the diagnosis of avulsion of the puborectalis muscle by tomographic ultrasound. 2011; 22:699-704. doi: [10.1007/s00192-010-1329-4](https://doi.org/10.1007/s00192-010-1329-4)


Reitz A, et al.  European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. 2004; 45:510-5. doi: [10.1016/j.eururo.2003.12.004](https://doi.org/10.1016/j.eururo.2003.12.004)


Winters JC, et al.  Urodynamic studies in adults: AUA/SUFU guideline. 2012; 188:2464-72. doi: [10.1016/j.juro.2012.09.081](https://doi.org/10.1016/j.juro.2012.09.081)


Brubaker L, et al.  Refractory idiopathic urge urinary incontinence and botulinum A injection. 2008; 180:217-22. doi: [10.1016/j.juro.2008.03.028](https://doi.org/10.1016/j.juro.2008.03.028)


Maher C and O'Rourke P.  Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial. 2011; 117:1435-1436. doi: [10.1097/AOG.0b013e31821daf31](https://doi.org/10.1097/AOG.0b013e31821daf31)


Boyles SH, et al.  Procedures for pelvic organ prolapse in the United States, 1979-1997. 2003; 188:108-15. doi: [10.1067/mob.2003.101](https://doi.org/10.1067/mob.2003.101)


Samuelsson EC, et al.  Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. 1999; 180:299-305. doi: [10.1016/s0002-9378(99)70203-6](https://doi.org/10.1016/s0002-9378(99)70203-6)


Santoro N and Komi J.  Prevalence and impact of vaginal symptoms among postmenopausal women. 2009; 6:2133-42. doi: [10.1111/j.1743-6109.2009.01335.x](https://doi.org/10.1111/j.1743-6109.2009.01335.x)


Coyne KS, et al.  The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. 2006; 49:1079-86. doi: [10.1016/j.eururo.2006.01.007](https://doi.org/10.1016/j.eururo.2006.01.007)


Coyne KS, et al.  The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. 2009; 103 Suppl 3:4-11. doi: [10.1111/j.1464-410X.2009.08371.x](https://doi.org/10.1111/j.1464-410X.2009.08371.x)


Dmochowski RR, et al.  Update of AUA guideline on the surgical management of female stress urinary incontinence. 2010; 183:1906-14. doi: [10.1016/j.juro.2010.02.2369](https://doi.org/10.1016/j.juro.2010.02.2369)


Handa VL, et al.  Pelvic floor disorders 5-10 years after vaginal or cesarean childbirth. 2011; 118:777-84. doi: [10.1097/AOG.0b013e3182267f2f](https://doi.org/10.1097/AOG.0b013e3182267f2f)


Luber KM, et al.  The demographics of pelvic floor disorders: current observations and future projections. 2001; 184:1496-501; discussion 1501-3. doi: [10.1067/mob.2001.114868](https://doi.org/10.1067/mob.2001.114868)


Sahai A, et al.  Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. 2007; 177:2231-6. doi: [10.1016/j.juro.2007.01.130](https://doi.org/10.1016/j.juro.2007.01.130)


Hu TW, et al.  Costs of urinary incontinence and overactive bladder in the United States: a comparative study. 2004; 63:461-5. doi: [10.1016/j.urology.2003.10.037](https://doi.org/10.1016/j.urology.2003.10.037)
These spacers are available to use for margins and padding with responsive utility classes. Combine these prefixes with a screen size and spacing scale to use them responsively.

| Classname prefix | What it does                  |
|:-----------------|:------------------------------|
| `.m-`            | `margin`                      |
| `.mx-`           | `margin-left`, `margin-right` |
| `.my-`           | `margin top`, `margin bottom` |
| `.mt-`           | `margin-top`                  |
| `.mr-`           | `margin-right`                |
| `.mb-`           | `margin-bottom`               |
| `.ml-`           | `margin-left`                 |

| Classname prefix | What it does                    |
|:-----------------|:--------------------------------|
| `.p-`            | `padding`                       |
| `.px-`           | `padding-left`, `padding-right` |
| `.py-`           | `padding top`, `padding bottom` |
| `.pt-`           | `padding-top`                   |
| `.pr-`           | `padding-right`                 |
| `.pb-`           | `padding-bottom`                |
| `.pl-`           | `padding-left`                  |

Spacing values are based on a `1rem = 16px` spacing scale, broken down into these units:

| Spacer/suffix  | Size in rems  | Rem converted to px |
|:---------------|:--------------|:--------------------|
| `1`            | 0.25rem       | 4px                 |
| `2`            | 0.5rem        | 8px                 |
| `3`            | 0.75rem       | 12px                |
| `4`            | 1rem          | 16px                |
| `5`            | 1.5rem        | 24px                |
| `6`            | 2rem          | 32px                |
| `7`            | 2.5rem        | 40px                |
| `8`            | 3rem          | 48px                |
| `auto`         | auto          | auto                |

Use `mx-auto` to horizontally center elements.

#### Examples
{: .no_toc }

In Markdown, use the `{: }` wrapper to apply custom classes:

```markdown
This paragraph will have a margin bottom of 1rem/16px at large screens.
{: .mb-lg-4 }

This paragraph will have 2rem/32px of padding on the right and left at all screen sizes.
{: .px-6 }
```

## Horizontal Alignment

| Classname               | What it does                     |
|:------------------------|:---------------------------------|
| `.float-left`           | `float: left`                    |
| `.float-right`          | `float: right`                   |
| `.flex-justify-start`   | `justify-content: flex-start`    |
| `.flex-justify-end`     | `justify-content: flex-end`      |
| `.flex-justify-between` | `justify-content: space-between` |
| `.flex-justify-around`  | `justify-content: space-around`  |

_Note: any of the `flex-` classes must be used on a parent element that has `d-flex` applied to it._

## Vertical Alignment

| Classname              | What it does                    |
|:-----------------------|:--------------------------------|
| `.v-align-baseline`    | `vertical-align: baseline`      |
| `.v-align-bottom`      | `vertical-align: bottom`        |
| `.v-align-middle`      | `vertical-align: middle`        |
| `.v-align-text-bottom` | `vertical-align: text-bottom`   |
| `.v-align-text-top`    | `vertical-align: text-top`      |
| `.v-align-top`         | `vertical-align: top`           |

## Display

Display classes aid in adapting the layout of the elements on a page:

| Class             |                         |
|:------------------|:------------------------|
| `.d-block`        | `display: block`        |
| `.d-flex`         | `display: flex`         |
| `.d-inline`       | `display: inline`       |
| `.d-inline-block` | `display: inline-block` |
| `.d-none`         | `display: none`         |

Use these classes in conjunction with the responsive modifiers.

#### Examples
{: .no_toc }

In Markdown, use the `{: }` wrapper to apply custom classes:

```markdown
This button will be hidden until medium screen sizes:

[ A button ](#url)
{: .d-none .d-md-inline-block }

These headings will be `inline-block`:

### heading 3
{: .d-inline-block }

### heading 3
{: .d-inline-block }
```
